BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2838445)

  • 1. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
    Hashimoto Y; Kagechika H; Kawachi E; Shudo K
    Jpn J Cancer Res; 1988 Apr; 79(4):473-83. PubMed ID: 2838445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
    Takahashi N; Breitman TR
    Arch Biochem Biophys; 1994 Oct; 314(1):82-9. PubMed ID: 7944409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's).
    Hashimoto Y; Kagechika H; Shudo K
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1300-7. PubMed ID: 2154975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The retinoic acid receptors alpha and beta are expressed in the human promyelocytic leukemia cell line HL-60.
    Hashimoto Y; Petkovich M; Gaub MP; Kagechika H; Shudo K; Chambon P
    Mol Endocrinol; 1989 Jul; 3(7):1046-52. PubMed ID: 2552297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.
    Nervi C; Grippo JF; Sherman MI; George MD; Jetten AM
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5854-8. PubMed ID: 2548190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the ligand-binding domain-containing region of retinoic acid receptors alpha, beta and gamma in Escherichia coli and evaluation of ligand-binding selectivity.
    Fukasawa H; Iijima T; Kagechika H; Hashimoto Y; Shudo K
    Biol Pharm Bull; 1993 Apr; 16(4):343-8. PubMed ID: 8395280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M; Breitman TR
    Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in retinoids studies].
    Kagechika H; Hashimoto Y; Kawachi E; Shudo K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2839-47. PubMed ID: 3052300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells.
    Kizaki M; Nakajima H; Mori S; Koike T; Morikawa M; Ohta M; Saito M; Koeffler HP; Ikeda Y
    Blood; 1994 Jun; 83(11):3289-97. PubMed ID: 8193364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of morphological and functional differentiation of human myeloid leukemia cells (HL-60 and LK) by a benzoic acid derivative of retinoic acid.
    Fabian I; Shvartzmayer S; Fibach E
    Leuk Res; 1987; 11(10):863-8. PubMed ID: 2824937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
    Clifford JL; Petkovich M; Chambon P; Lotan R
    Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergists for retinoid in cellular differentiation of human promyelocytic leukemia cells HL-60.
    Umemiya H; Kawachi E; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1827-9. PubMed ID: 8536354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
    Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
    Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant effects of synthetic retinoids.
    Koyama T; Shibakura M
    Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells.
    Von Schroeder HP; Hashimoto Y; Heersche JN
    Teratology; 1994 Jul; 50(1):54-62. PubMed ID: 7974255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
    Koyama T; Hirosawa S
    Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic retinoids, retinobenzoic acids, Am80, Am580 and Ch55 regulate morphogenesis in chick limb bud.
    Tamura K; Kagechika H; Hashimoto Y; Shudo K; Ohsugi K; Ide H
    Cell Differ Dev; 1990 Oct; 32(1):17-26. PubMed ID: 2090329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring.
    Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K
    J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity gels for purification of retinoid-specific binding protein (RSBP).
    Kagechika H; Hashimoto Y; Kawachi E; Shudo K
    Biochem Biophys Res Commun; 1988 Aug; 155(1):503-8. PubMed ID: 2843186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.